Singapore blue arboreal tarantula peptide Lv1a preferentially targets NaV1.6 with new world–like pharmacological mechanism
- 28 November 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 244, 117565
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (GNT1188959)
- National Health and Medical Research Council (APP1072113)
This publication has 24 references indexed in Scilit:
- Venom peptides regulating Ca2+ homeostasis: neuroprotective potentialTrends in Pharmacological Sciences, 2025
- Highly accurate protein structure prediction with AlphaFoldNature, 2021
- Structural Basis for High-Affinity Trapping of the NaV1.7 Channel in Its Resting State by Tarantula ToxinMolecular Cell, 2020
- Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseasesBiochemical Pharmacology, 2020
- Spider venom-derived peptide induces hyperalgesia in Nav1.7 knockout mice by activating Nav1.9 channelsNature Communications, 2020
- Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider ToxinCell, 2019
- Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approachesNeuropharmacology, 2018
- The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular ComplexesJournal of Molecular Biology, 2016
- Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cellsBiochemical Pharmacology, 2012
- Intersexual variations in the pharmacological properties of Coremiocnemis tropix (Araneae, Theraphosidae) spider venomToxicon, 2009